Treatment of Adult Nocturia

Initial Diagnostic Approach

The European Urology guideline recommends a bladder diary (frequency-volume chart) for 3 days to distinguish between different mechanisms of nocturia, including nocturnal polyuria, 24-hour polyuria, and reduced bladder capacity 1, 2, 3
The European Association of Urology suggests that nocturnal polyuria is defined as >33% of 24-hour urine output occurring at night, and 24-hour polyuria is defined as >3L total urine output per day 3
Reduced bladder capacity is characterized by small volume voids with urgency, according to The Journal of Urology 4

The European Urology guideline recommends that all patients receive behavioral interventions, including fluid regulation, medication timing adjustment, and sleep hygiene, before pharmacotherapy 1, 5
The guideline also recommends treating underlying conditions, such as OSA, heart failure, hypertension, and diabetes, to manage nocturia 1, 7
The American Urological Association suggests that desmopressin is the only medication specifically indicated for nocturia due to nocturnal polyuria, with a dosing of 25 µg for women and 50 µg for men (single daily dose) 7

The European Urology guideline advises against assuming nocturia is urological without bladder diary confirmation, as sleep disorders, cardiovascular disease, and nocturnal polyuria are frequently causative 1, 8
The guideline also recommends avoiding treating nocturia pharmacologically before addressing medication timing, excessive fluid intake patterns, and underlying medical conditions 1, 7
The European Association of Urology suggests recognizing treatment conflicts, such as preventing diuresis/natriuresis to reduce nocturia, which may worsen underlying cardiovascular/renal conditions 1, 7
The International Continence Society recommends setting realistic expectations, as many medical conditions causing nocturia have no effective treatment or treatment may be harmful 1, 7